Ignite Creation Date:
2024-05-06 @ 8:27 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06385080
Status:
RECRUITING
Last Update Posted:
2024-06-20
First Post:
2024-04-23
Brief Title:
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With RecurrentMetastatic Head and Neck Cancer
Sponsor:
Janssen Research Development LLC
Organization:
Janssen Research Development LLC
Organization Data
Organization:
Janssen Research Development LLC
Class:
INDUSTRY
Study ID:
61186372HNC2002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Janssen Research Development LLC
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None